Back to Treatments

Treatment

Dupilumab

2
Conditions
118
Trials
15K
Participants
66%
Average Safety

Condition Evidence

Chronic Sinusitis

10 trials · 5,000 participants

90% effectiveness · 72% safety

Eczema

108 trials · 10K participants

90% effectiveness · 60% safety
Dupilumab | DFDA